Analyst Ratings for Ultragenyx Pharma (RARE)
RARE Rating Summary
RARE Price Target Summary
- Highest: $77.00 (Jefferies)
- Lowest: $16.00 (Baird)
- Average: $32.42
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$32.42 (+123%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 52%
Rating Score: 5 / 10
Percentile Rank: 52%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/14/2026 | UBS | N/A | New Coverage | Neutral (N/A) |
16.00 (N/A) |
14.92 (14.54) |
-2.55% | Details |
| 9/3/2026 | Morgan Stanley » Updated 9/21/2026 |
Maxwell Skor | Downgrade | Equalweight (Overweight) |
20.00 (18.00) |
26.53 (14.54) |
-45.19% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
